- Home
- NTRB vs VANI Comparison
NTRB vs VANI Comparison
Compare NTRB & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- VANI
- Stock Information
- Founded
- NTRB 2016
- VANI 1998
- Country
- NTRB United States
- VANI United States
- Employees
- NTRB N/A
- VANI N/A
- Industry
- NTRB Industrial Specialties
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NTRB Health Care
- VANI Health Care
- Exchange
- NTRB Nasdaq
- VANI Nasdaq
- Market Cap
- NTRB 84.1M
- VANI 69.3M
- IPO Year
- NTRB N/A
- VANI 2014
- Fundamental
- Price
- NTRB $7.46
- VANI $1.15
- Analyst Decision
- NTRB Buy
- VANI Strong Buy
- Analyst Count
- NTRB 1
- VANI 1
- Target Price
- NTRB $13.00
- VANI $3.00
- AVG Volume (30 Days)
- NTRB 216.4K
- VANI 83.2K
- Earning Date
- NTRB 12-04-2024
- VANI 03-25-2025
- Dividend Yield
- NTRB N/A
- VANI N/A
- EPS Growth
- NTRB N/A
- VANI N/A
- EPS
- NTRB N/A
- VANI N/A
- Revenue
- NTRB $2,021,771.00
- VANI N/A
- Revenue This Year
- NTRB $7.95
- VANI N/A
- Revenue Next Year
- NTRB $538.25
- VANI N/A
- P/E Ratio
- NTRB N/A
- VANI N/A
- Revenue Growth
- NTRB N/A
- VANI N/A
- 52 Week Low
- NTRB $2.22
- VANI $1.01
- 52 Week High
- NTRB $11.78
- VANI $7.80
- Technical
- Relative Strength Index (RSI)
- NTRB 55.21
- VANI 43.02
- Support Level
- NTRB $6.68
- VANI $1.12
- Resistance Level
- NTRB $8.24
- VANI $1.19
- Average True Range (ATR)
- NTRB 0.74
- VANI 0.03
- MACD
- NTRB -0.11
- VANI 0.00
- Stochastic Oscillator
- NTRB 43.32
- VANI 42.86
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.